Yale University researchers developed an enhanced multiplex genome editing technique, significantly increasing the number of accurate edits per cell while minimizing off-target mutations. This advancement, published in Nature Communications, overcomes limitations of traditional CRISPR-Cas9 approaches that rely on double-strand breaks and suffers from inefficiency in simultaneous multi-site editing. The breakthrough holds promise for elucidating complex disease genetics and advancing therapeutic gene editing.